Evidence map›Paper›PMID 35194215›Full record

ReviewNature reviews. Nephrology2022

Epidemiology of haemodialysis outcomes.

Aminu K Bello, Ikechi G Okpechi, Mohamed A Osman, Yeoungjee Cho, Htay Htay, Vivekanand Jha, Marina Wainstein, David W Johnson

3 registry-linked trialsOpen access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nature reviews. Nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 325 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
325citing papers in PubMed, 10 pooled it
72.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06243900 unknown statusnot on this mapstarted 2024, after this paper: background citation

NIRS: a Tool for the Diagnosis of Residual Renal Function Injury in Hemodialysis Patients

TypeobservationalSponsorYuanjun YangRan2024 to 2026Enrolled30ConditionsEnd-stage Renal Disease (ESRD)
NCT06845605 recruitingnot on this mapstarted 2024, after this paper: background citation

A Qualitative Exploration Study of Healthcare Professionals' Perspectives in Haemodialysis Needling to Enhance Patients' Overall Experience

TypeobservationalSponsorEast and North Hertfordshire NHS TrustRan2024 to 2025Enrolled16ConditionsPerspective of Healthcare Professionals Haemodialysis Needling, Dialysis
NCT06963853 recruitingnot on this map

Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis

TypeobservationalSponsorWestern Galilee Hospital-NahariyaRan2022 to 2027Enrolled200ConditionsSepsis, HemodialysisArmsBlood cultures will be obtained from three sources: 1. The central venous catheter (CVC), 2. The dialysis machine circuit, and 3. A peripheral vein
3 · Its place in the literature

Who cites it

325 citing papers in PubMed, 10 syntheses or guidelines pooled it, 551 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of Exercise on Parathyroid Hormone Levels in Dialysis Patients: A Systematic Review and Meta-Analysis.Hemodialysis international. International Symposium on Home Hemodialysis · 2026
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Effect of transcutaneous vagus nerve stimulation in hemodialysis patients: A randomized controlled trial.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Intradialytic Exercise: Effects on Arterial Stiffness and Gait Speed in Patients Undergoing Hemodialysis.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Trial
  16. Trial
  17. Article
  18. Article
  19. Article
  20. Observational

265 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Aminu K BelloDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.ORCID http://orcid.org/0000-0002-6905-5937
Ikechi G OkpechiDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Mohamed A OsmanDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Yeoungjee ChoCentre for Kidney Disease Research, University of Queensland, Brisbane, Queensland, Australia.
Htay HtayDepartment of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
Vivekanand JhaGeorge Institute for Global Health, UNSW, New Delhi, India.ORCID http://orcid.org/0000-0002-8015-9470
Marina WainsteinCentre for Kidney Disease Research, University of Queensland, Brisbane, Queensland, Australia.ORCID http://orcid.org/0000-0002-5915-6101
David W JohnsonCentre for Kidney Disease Research, University of Queensland, Brisbane, Queensland, Australia. david.johnson2@health.qld.gov.au.ORCID http://orcid.org/0000-0001-5491-3460
The University of Queensland · AUUniversity of Alberta · CAGeorge Institute for Global Health · INSingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world, accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis. Over the last six decades since the inception of HD, dialysis technology and patient access to the therapy have advanced considerably, particularly in high-income countries. However, HD availability, accessibility, cost and outcomes vary widely across the world and, overall, the rates of impaired quality of life, morbidity and mortality are high. Cardiovascular disease affects more than two-thirds of people receiving HD, is the major cause of morbidity and accounts for almost 50% of mortality. In addition, patients on HD have high symptom loads and are often under considerable financial strain. Despite the many advances in HD technology and delivery systems that have been achieved since the treatment was first developed, poor outcomes among patients receiving HD remain a major public health concern. Understanding the epidemiology of HD outcomes, why they might vary across different populations and how they might be improved is therefore crucial, although this goal is hampered by the considerable heterogeneity in the monitoring and reporting of these outcomes across settings.

Indexed as

Cardiovascular DiseasesKidney Failure, ChronicHumansQuality of LifeRenal DialysisRenal Replacement Therapy

Identifiers

PMID35194215
PMCPMC8862002
OpenAlexW4213281001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.